| mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |